Clinical Trials Sponsored by GenMont Biotech Incorporation

Total 50 results

GenMont Biotech Incorporation

Completed

Effects of Genmont Probiotic on Improve the Level of Blood Glucose and Other Diabetic Associate Parameter in Type 2 Diabetes Patients

Type 2 Diabetes

Taiwan
GenMont Biotech Incorporation
Biomedical Development Corporation

Completed

the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis (PAR)

Probiotics | Perennial Allergic Rhinitis | Lactobacillus Paracasei GMNL-32 (eN-Lac®)

Taiwan
GenMont Biotech Incorporation
Kuo General Hospital

Completed

Analysis of Ameliorative Effects of Oral Probiotics on Bacterial Vaginosis

Bacterial Vaginosis

Taiwan
GenMont Biotech Incorporation
Mackay Memorial Hospital

Recruiting

To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast Cancer

Breast Cancer

Taiwan
GenMont Biotech Incorporation
Chang Gung Memorial Hospital

Withdrawn

Evaluation of the Effect of Wismemo on Alzheimer's Dementia Patients

Alzheimer Disease
GenMont Biotech Incorporation
Chung Shan Medical University

Recruiting

To Evaluate the Beneficial Effect of Probiotics on DKD Patients and the Role of Gut Microbiota Modulation

Diabetic Kidney Disease

Taiwan
GenMont Biotech Incorporation
National Science Council, Taiwan

Completed

Probiotics and Allergic Diseases (probiotics)

Asthma | Atopic Dermatitis

Taiwan
GenMont Biotech Incorporation
Fu Jen Catholic University Hospital

Recruiting

To Evaluate the Beneficial Effect of Probiotics on NAFLD Patients and the Role of Gut Microbiota Modulation

Non-Alcoholic Fatty Liver Disease

Taiwan
GenMont Biotech Incorporation
Chia Nan University of Pharmacy and Science

Completed

The Safety and Efficacy Evaluation of Hair Products Containing Probiotics

Skin Problems

Taiwan
GenMont Biotech Incorporation
Kaohsiung Medical University Chung-Ho Memorial Hospital

Completed

To Evaluate the Efficacy of Probiotics Toothpastes in Improvement of Gingivitis and Prevention of Periodontal Diseases Via Modulating the Oral Microbiota

Gingivitis

Taiwan
GenMont Biotech Incorporation
Chia Nan University of Pharmacy and Science

Completed

Efficacy Evaluation of the Probiotics Containing Skincare Products on Skin

Skin Problems

Taiwan
Olympus Biotech Corporation

Completed

The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Northern Europe The TRANS-North Study (TRANS-North)

Diabetic Foot Ulcer of Neuropathic Origin

Belgium, Germany, Poland, Croatia, Bulgaria, Denmark, Slovakia, Hungary, Netherlands, Sweden
Olympus Biotech Corporation

Completed

The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Southern Europe The TRANS-South Study (TRANS-South)

Diabetic Foot Ulcer of Neuropathic Origin

France, Italy, Hungary, Czech Republic
Olympus Biotech Corporation

Completed

A Pilot Study to Evaluate an Osteogenic Protein 1 (OP-1) Putty Spinal System and an Autograft Spinal System

Degenerative Disc Disease

United States
Olympus Biotech Corporation

Completed

Study of OP-1 Putty in Uninstrumented Posterolateral Fusions

Degenerative Lumbar Spondylolisthesis

United States, Canada
Olympus Biotech Corporation

Completed

A Prospective Pilot Study of the OP-1 Putty in Uninstrumented Posterolateral Fusions

Degenerative Lumbar Spondylolisthesis

United States
Olympus Biotech Corporation

Completed

OP Device vs. Bone Autograft for the Treatment of Tibial Nonunions

Tibial Nonunions

United States
Olympus Biotech Corporation

Completed

OP-1 Putty for Posterolateral Fusions

Degenerative Lumbar Spondylolisthesis

United States, Canada
NatureWise Biotech & Medicals Corporation

Completed

A Safety and Pharmacokinetic Study of NBM-BMX Administered Orally to Patients With Advanced Cancer

Malignant Neoplasm

United States
NatureWise Biotech & Medicals Corporation

Completed

A Safety and Pharmacokinetic Study of NBM-BMX Administered Orally to Asian Patients With Advanced Cancer

Malignant Neoplasm

Taiwan
Biotest Pharmaceuticals Corporation
Biotest

Completed

BT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Multiple Myeloma

Multiple Myeloma

United States
Biotest Pharmaceuticals Corporation
Biotest

Completed

Safety and Dose Determining Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States
Biotest Pharmaceuticals Corporation
Biotest

Completed

Safety and Dose Determining Multi-dose Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States
Aduro Biotech, Inc.
Incyte Corporation

Terminated

Safety and Efficacy of CRS-207 With Epacadostat in Platinum Resistant Ovarian, Fallopian or Peritoneal Cancer (SEASCAPE)

Platinum-resistant Ovarian Cancer | Platinum-resistant Fallopian Cancer | Platinum-resistant Peritoneal Cancer

United States, Canada
Biotest Pharmaceuticals Corporation

Withdrawn

Nabi-HB Administered Subcutaneously in Patients With Hepatitis B Virus Post Liver Transplantation (Nabi-HB-SC)

Hepatitis B, Chronic
Biotest Pharmaceuticals Corporation

Completed

Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation

Hepatitis B Virus Associated Liver Disease

United States
Biotest Pharmaceuticals Corporation

Completed

Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.

Liver Cirrhosis | Hepatitis, Viral, Human | Hepatocellular Carcinoma | Hepatitis C Infection | Viruses

United States
Great Novel Therapeutics Biotech & Medicals Corporation

Recruiting

Chidamide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (R/R PTCL)

Relapsed or Refractory Peripheral T-cell Lymphoma

Taiwan
Great Novel Therapeutics Biotech & Medicals Corporation

Recruiting

Chidamide + Regorafenib in Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma (HCC)

Taiwan
Honeybrains Biotech LLC
Cognitive Research Corporation

Completed

Safety and Efficacy of HB-1 for Panic Disorder

Panic Disorder

United States
Mycenax Biotech Inc.
TSH Biopharm Corporation Limited

Terminated

A Multicentre Study to Evaluate the Efficacy and Safety of ENIA11 in Patients With Ankylosing Spondylitis

Ankylosing Spondylitis

Taiwan
National Taiwan University Hospital
TCM Biotech International Corporation

Recruiting

Radiation Cystitis Treated With Pentosan Polysulfate Sodium Trial

Radiation Cystitis

Taiwan
Donald Mathews
Masimo Corporation

Completed

Halo Index and Adaptive Alarm Thresholds During Routine PACU Inpatient Care: "Normal" vs. "Non-normal" Recovery (Halo)

Patients Recovering From Inpatient Surgery

United States
Transwell Biotech Co., Ltd.
A2 Healthcare Taiwan Corporation

Completed

TWB-103 for Adult Patients With Split-Thickness Skin Graft Donor Site Wounds

Donor Site Complication

Japan, Taiwan
University of Leeds
Celgene Corporation; Oncolytics Biotech; Myeloma UK

Unknown

Viral Immunotherapy in Relapsed/Refractory Multiple Myeloma (MUKeleven)

Multiple Myeloma

United Kingdom
WomenX Biotech Limited
Hong Kong Science and Technology Parks Corporation

Recruiting

Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer-HPV DNA and Other Biomarkers in Urine

Cervical Cancer

Hong Kong
Washington University School of Medicine
Incyte Corporation; PapiVax Biotech, Inc.

Recruiting

Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma

Unmethylated Glioblastoma

United States
Swiss Tropical & Public Health Institute
Pevion Biotech Ltd; Mymetics Corporation

Completed

Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania (PMAL03)

Falciparum Malaria

Tanzania
isRed Pharma & Biotech Research Corporation
Yung Shin Pharmaceutical Ind. Co., Ltd.

Unknown

A Pharmacokinetic Study to Evaluate the Bioequivalence of a Test Formulation Compared to an Equivalent Dose of a Reference Drug Product

Healthy Adult Subjects

Taiwan
UnicoCell Biomed CO. LTD
Protech Pharmaservices Corporation (PPC)

Completed

Adipose-derived Stem Cells (ADSCs) for Moderate to Severe Chronic Kidney Disease

Moderate to Severe Chronic Kidney Disease

Taiwan
Pharming Technologies B.V.
Laboratory Corporation of America; CMIC Co, Ltd. Japan; Axial Biotech, Inc

Recruiting

An Open-Label Study to Assess the Safety & Efficacy of Leniolisib in Japanese Patients With APDS

APDS Gene Mutation

Japan
Neurological Associates of West Los Angeles
EmCyte Corporation; BioRich Medical

Completed

Safety and Efficacy of PRP for Treatment of Disc Pain

Discogenic Pain

United States
H. Lee Moffitt Cancer Center and Research Institute
Celgene Corporation; Ortho Biotech Clinical Affairs, L.L.C.

Completed

Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed Multiple Myeloma (MM)

Multiple Myeloma

United States
US Biotest, Inc.
National Institutes of Health (NIH); Integra LifeSciences Corporation

Completed

Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers

Diabetic Foot | Foot Ulcer, Diabetic

United States
Larry Cripe, MD
Celgene Corporation; Ortho Biotech Clinical Affairs, L.L.C.; Walther Cancer Institute

Terminated

Azacitidine and Erythropoietin Versus Azacitidine Alone for Patients With Low-Risk Myelodysplastic Syndromes

Myelodysplastic Syndromes

United States
Mridula George, MD
National Cancer Institute (NCI); Incyte Corporation; Oncolytics Biotech

Recruiting

INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study

Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Triple-negative Breast Cancer | Metastatic Triple-Negative Breast Carcinoma | Locally Advanced Breast Carcinoma

United States
Tokai University
Abbott Medical Devices; Kaneka Medical America LLC; Terumo Medical Corporation; Asahi Intech and other collaborators

Completed

Guidewire for Chronic Total Occlusion (G-FORCE)

Coronary Occlusion

Japan
City of Hope Medical Center
CSL Behring; Grifols Therapeutics LLC; Grifols Biologicals, LLC; Charta Foundation and other collaborators

Withdrawn

Study of First TIME Immunotolerance Induction in Severe Hemophilia A Patients With Inhibitor at High Risk of Failure: Comparison With FVIII Concentrates With or Without Von Willebrand Factor - RES.I.S.T. Naive (RESIST NAIVE)

Severe Hemophilia A
City of Hope Medical Center
CSL Behring; Grifols Therapeutics LLC; Grifols Biologicals, LLC; Charta Foundation and other collaborators

Completed

Rescue Immunotolerance Study in Induction of Immune Tolerance (ITI)-Experienced Patients (RES.I.S.T. Experienced) (RESIST EXP)

Severe Hemophilia A

United States
Region Örebro County
University of Patras; Siemens Corporation, Corporate Technology; Fundacio Clinic... and other collaborators

Active, not recruiting

Artificial Intelligence Supporting CAncer Patients Across Europe - the ASCAPE Project (ASCAPE)

Quality of Life | Breast Cancer | Prostate Cancer | Toxicity | Survivorship

Sweden, Greece, Spain, United Kingdom

Clinical Trials Sponsored by GenMont Biotech Incorporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations